Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 8/25/08 → 10/31/11 |
Financiación
- Grifols Biologicals Inc: 5.851,00 US$
A Postmarketing Obervational Study to Assess the Efficacy and Safety of the Factor VIII/von Willebrand Factor Complex (Human), Alphanate, in Preventing Excessive Bleeding During Surgery in Subjects with Congenital Type 3 von Willebrand Disease
- Radulescu, Vlad (PI)